Defining the Most Informative Intermediate Clinical Endpoints for Patients Treated with Salvage Radiotherapy for Prostate-specific Antigen Rise After Radical Prostatectomy-Reference-Cited by-同舟云学术

Defining the Most Informative Intermediate Clinical Endpoints for Patients Treated with Salvage Radiotherapy for Prostate-specific Antigen Rise After Radical Prostatectomy

Published:2021-04 Issue:2 Volume:4 Page:301-304
ISSN:2588-9311
Container-title:European Urology Oncology
language:en
Short-container-title:European Urology Oncology

Author:

Martini Alberto,Fossati Nicola,Karnes R. Jeffrey,Boorjian Stephen A.,Boeri Luca,Bossi Alberto,Di Muzio Nadia,Cozzarini Cesare,Noris Chiorda Barbara,Gandaglia Giorgio,Robesti Daniele,Bartkowiak Detlef,Böhmer Dirk,Shariat Shahrokh F.,Goldner Gregor,Battaglia Antonino,Joniau Steven,Berghen Charlien,De Meerleer Gert,Fonteyne Valérie,Ost Piet,Van Poppel Hein,Montorsi Francesco,Wiegel Thomas,Briganti Alberto

Publisher

Elsevier BV

Subject

Urology,Radiology, Nuclear Medicine and imaging,Oncology,Surgery

Reference16 articles.

1. Stratification of high-risk prostate cancer into prognostic categories: a European multi-institutional study;Joniau;Eur Urol,2015

2. Natural history of surgically treated high-risk prostate cancer;Briganti;Urol Oncol,2015

3. EAU-ESTRO-SIOG guidelines on prostate cancer. Part 1: screening, diagnosis, and local treatment with curative intent;Mottet;Eur Urol,2017

4. Contemporary update of a multi-institutional predictive nomogram for salvage radiotherapy after radical prostatectomy;Tendulkar;J Clin Oncol,2016

5. Prognostic value of biochemical recurrence following treatment with curative intent for prostate cancer: a systematic review;Van den Broeck;Eur Urol,2019

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Circulating Biomarkers Predictive of Treatment Response in Patients with Hormone-sensitive or Castration-resistant Metastatic Prostate Cancer: A Systematic Review;European Urology Oncology;2024-05

2. Evidence-based Urology: Surrogate Endpoints – For;European Urology Focus;2021-11